Enhanced trapping of hiv-1 by human cervicovaginal mucus is associated with lactobacillus crispatus-dominant microbiota

mBio

Volumn 6, Issue 5, 2015, Pages 1-9

  Nunn, Kenetta L ^a   Wang, Ying Ying ^b   Harit, Dimple ^c   Humphrys, Michael S ^d   Ma, Bing ^d   Cone, Richard ^b   Ravel, Jacques ^d   Lai, Samuel K ^a,c,e  

^a USA and North Carolina State University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of North Carolina   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CERVICOVAGINAL MUCUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GARDNERELLA VAGINALIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LACTOBACILLUS CRISPATUS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX MUCUS; VAGINA FLORA; VAGINITIS; VIRION; ADULT; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MUCUS; PH; UTERINE CERVIX; VAGINA; VIROLOGY; YOUNG ADULT;

ADULT; CERVIX UTERI; FEMALE; GARDNERELLA VAGINALIS; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; LACTOBACILLUS; MUCUS; VAGINA; YOUNG ADULT;

EID: 84946564080     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01084-15     Document Type: Article

References (47)

1. Gipson IK. 2001. Mucins of the human endocervix. Front Biosci 6:D1245-D1255. http://dx.doi.org/10.2741/Gipson.
2. Kieweg SL, Geonnotti AR, Katz DF. 2004. Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis. J Pharm Sci 93:2941-2952. http://dx.doi.org/10.1002/jps.20194.
3. Kieweg SL, Katz DF. 2006. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. J Biomech Eng 128:540-553. http://dx.doi.org/10.1115/1.2206198.
4. Odeblad E. 1964. Intracavitary circulation of aqueous material in the human vagina. Acta Obstet Gynecol Scand 43:360-368. http://dx.doi.org/10.3109/00016346409162686.
5. Wagner G, Levin RJ. 1980. Electrolytes in vaginal fluid during the menstrual cycle of coitally active and inactive women. J Reprod Fertil 60: 17-27. http://dx.doi.org/10.1530/jrf.0.0600017.
6. Boskey ER, Cone RA, Whaley KJ, Moench TR. 2001. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16:1809-1813. http://dx.doi.org/10.1093/humrep/16.9.1809.
7. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram-stain interpretation. J Clin Microbiol 29:297-301.
8. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. 2011. Vaginal microbiome of reproductiveage women. Proc Natl Acad Sci U S A 108(Suppl 1):4680-4687. http://dx.doi.org/10.1073/pnas.1002611107.
9. Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J. 2012. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4:132ra152. http://dx.doi.org/10.1126/scitranslmed.3003605.
10. Allsworth JE, Peipert JF. 2007. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 109:114-120. http://dx.doi.org/10.1097/01.AOG.0000247627.84791.91.
11. Lai SK, Hida K, Shukair S, Wang YY, Figueiredo A, Cone R, Hope TJ, Hanes J. 2009. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 83: 11196-11200. http://dx.doi.org/10.1128/JVI.01899-08.
12. Shukair SA, Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, Lakougna HY, Hammond C, Kiser PF, Hope TJ. 2013. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol 6:427-434. http://dx.doi.org/10.1038/mi.2012.87.
13. O’Hanlon DE, Moench TR, Cone RA. 2013. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 8:e80074. http://dx.doi.org/10.1371/journal.pone.0080074.
14. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. 2012. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 9:e1001251. http://dx.doi.org/10.1371/journal.pmed.1001251.
15. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550. http://dx.doi.org/10.1016/S0140-6736(97)01063-5.
16. Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes JA, Gurguis A, Faro S. 2001. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 185:375-379. http://dx.doi.org/10.1067/mob.2001.115867.
17. Witkin SS, Mendes-Soares H, Linhares IM, Jayaram A, Ledger WJ, Forney LJ. 2013. Influence of vaginal bacteria and D-and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. mBio 4:e00460-13. http://dx.doi.org/10.1128/mBio.00460-13.
18. Lai SK, Wang YY, Hida K, Cone R, Hanes J. 2010. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A 107:598-603. http://dx.doi.org/10.1073/pnas.0911748107.
19. Bettelheim FA. 1963. Physical chemistry of mucins. Ann N Y Acad Sci 106:247-258. http://dx.doi.org/10.1111/j.1749-6632.1963.tb16642.x.
20. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14-22. http://dx.doi.org/10.1016/0002-9343(83)91112-9.
21. Olmsted SS, Meyn LA, Rohan LC, Hillier SL. 2003. Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis 30:257-261. http://dx.doi.org/10.1097/00007435-200303000-00016.
22. Brotman RM, Ravel J, Cone RA, Zenilman JM. 2010. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 86:297-302. http://dx.doi.org/10.1136/sti.2009.040592.
23. Ravel J, Brotman RM, Gajer P, Ma B, Nandy M, Fadrosh DW, Sakamoto J, Koenig SS, Fu L, Zhou X, Hickey RJ, Schwebke JR, Forney LJ. 2013. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1:29. http://dx.doi.org/10.1186/2049-2618-1-29.
24. Aldunate M, Tyssen D, Johnson A, Zakir T, Sonza S, Moench T, Cone R, Tachedjian G. 2013. Vaginal concentrations of lactic acid potently inactivate HIV. J Antimicrob Chemother 68:2015-2025. http://dx.doi.org/10.1093/jac/dkt156.
25. O’Hanlon DE, Moench TR, Cone RA. 2011. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis 11:200. http://dx.doi.org/10.1186/1471-2334-11-200.
26. Olmsted SS, Dubin NH, Cone RA, Moench TR. 2000. The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril 73:687-693. http://dx.doi.org/10.1016/S0015-0282(99)00640-8.
27. Redondo-Lopez V, Cook RL, Sobel JD. 1990. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 12:856-872. http://dx.doi.org/10.1093/clinids/12.5.856.
28. Valore EV, Park CH, Igreti SL, Ganz T. 2002. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 187:561-568. http://dx.doi.org/10.1067/mob.2002.125280.
29. Olmsted SS, Khanna KV, Ng EM, Whitten ST, Johnson ON III, Markham RB, Cone RA, Moench TR. 2005. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis 5:79. http://dx.doi.org/10.1186/1471-2334-5-79.
30. Antonio MA, Petrina MA, Meyn LA, Hillier SL. 2013. P3.267 Women colonised by Lactobacillus crispatus have a lower risk of acquisition of bacterial vaginosis (BV) than women colonised by other lactobacilli. Sex Transm Infect 89(Suppl 1):A232. http://dx.doi.org/10.1136/sextrans-2013-051184.0723.
31. Ojala T, Kankainen M, Castro J, Cerca N, Edelman S, Westerlund-Wikström B, Paulin L, Holm L, Auvinen P. 2014. Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics 15:1070. http://dx.doi.org/10.1186/1471-2164-15-1070.
32. Briselden AM, Moncla BJ, Stevens CE, Hillier SL. 1992. Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora. J Clin Microbiol 30:663-666.
33. Macklaim JM, Gloor GB, Anukam KC, Cribby S, Reid G. 2011. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci U S A 108(Suppl 1):4688-4695. http://dx.doi.org/10.1073/pnas.1000086107.
34. Srinivasan S, Morgan MT, Fiedler TL, Djukovic D, Hoffman NG, Raftery D, Marrazzo JM, Fredricks DN. 2015. Metabolic signatures of bacterial vaginosis. mBio 6:e00204-15. http://dx.doi.org/10.1128/mBio.00204-15.
35. Balkus JE, Mitchell C, Agnew K, Liu C, Fiedler T, Cohn SE, Luque A, Coombs R, Fredricks DN, Hitti J. 2012. Detection of hydrogen peroxideproducing lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women. BMC Infect Dis 12: 188. http://dx.doi.org/10.1186/1471-2334-12-188.
36. Lai SK, Wang YY, Cone R, Wirtz D, Hanes J. 2009. Altering mucus rheology to “solidify” human mucus at the nanoscale. PLoS One 4:e4294. http://dx.doi.org/10.1371/journal.pone.0004294.
37. Lai SK, Wang YY, Wirtz D, Hanes J. 2009. Micro-and macrorheology of mucus. Adv Drug Deliv Rev 61:86-100. http://dx.doi.org/10.1016/j.addr.2008.09.012.
38. Cole AM. 2006. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol 306:199-230. http://dx.doi.org/10.1097/01.lgt.0000265775.52044.2b.
39. Doss M, White MR, Tecle T, Hartshorn KL. 2010. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 87:79-92. http://dx.doi.org/10.1189/jlb.0609382.
40. Kremer J, Jager S. 1992. The significance of antisperm antibodies for sperm-cervical mucus interaction. Hum Reprod 7:781-784.
41. Wang YY, Kannan A, Nunn KL, Murphy MA, Subramani DB, Moench T, Cone R, Lai SK. 2014. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol 7:1036-1044. http://dx.doi.org/10.1038/mi.2013.120.
42. Katz DF, Drobnis EZ, Overstreet JW. 1989. Factors regulating mammalian sperm migration through the female reproductive tract and oocyte vestments. Gamete Res 22:443-469. http://dx.doi.org/10.1002/mrd.1120220410.
43. Masters WH, Johnson VE. 1966. Human sexual response. Little Brown, Boston, MA.
44. Lai SK, O’Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, Hanes J. 2007. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A 104:1482-1487. http://dx.doi.org/10.1073/pnas.0608611104.
45. Apgar J, Tseng Y, Fedorov E, Herwig MB, Almo SC, Wirtz D. 2000. Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles. Biophys J 79:1095-1106. http://dx.doi.org/10.1016/S0006-3495(00)76363-6.
46. Crocker JC, Hoffman BD. 2007. Multiple-particle tracking and two-point microrheology in cells. Methods Cell Biol 83:141-178. http://dx.doi.org/10.1016/S0091-679X(07)83007-X.
47. Fadrosh DW, Ma B, Gajer P, Sengamalay N, Ott S, Brotman RM, Ravel J. 2014. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2:6. http://dx.doi.org/10.1186/2049-2618-2-6.